Drug abuse and HIV/AIDS researchers across the globe are taking advantage of local meetings to bridge the regional gap that often hinders the exchange of research ideas and the development of constructive collaborations. Meetings were held recently in Malaysia, Norway, and Ukraine
The Anti Narcotic-Coordinating Center of the Thai National Council on Social Welfare has translated articles from NIDA Notes to make the material more accessible to researchers and policymakers in the region.
The 42nd American Society of Addiction Medicine (ASAM) annual meeting, held this past April, gathered addiction researchers, providers, and professionals to exchange ideas and information and explore new and innovative science-based addiction treatment models. NIDA International Program director Steven W. Gust, Ph.D., joined his colleagues to participate in two symposiums. The first addressed innovative models of addiction treatment from the international context.
The breadth of dual-diagnosis issues found internationally and how they are manifest in three different national settings was the focus of a symposium at the American Society of Addiction Medicine (ASAM) 43rd Medical-Scientific Conference, which was held April 19–22, 2012, in Atlanta. Carlos Roncero, M.D., Ph.D., associate professor of psychiatry at the Autonomous University of Barcelona and chief of the drug addiction unit at Vall d’Hebron University Hospital, described the issues and treatment approaches in Spain.
Drs. Zabransky (left) and Bém at a reception at the mayor’s residence.
Two former Hubert H. Humphrey Fellows, Pavel Bém, M.D., and Tomas Zabransky, M.D., Ph.D., were organizers of a meeting on urban drug policy in Prague that led to the adoption of the Prague Declaration, a set of seven principles of effective drug policies and a call for greater participation of urban leaders in forming drug policies.
“Find good partners, start small, and take advantage of every research training and funding opportunity available.” That was the theme of presenters at the 16th Annual NIDA International Forum, which featured reports on U.S. initiatives to improve evidence-based drug treatment, research training, and policy implementation around the world.